Journals of the American College of Cardiology

• Renal Denervation: Antihypertensive or Gizmo Idolatry? A hypertension expert's view of the current status of renal denervation for resistant hypertension.
  Journal of the American College of Cardiology, March 20, 2025
• Accelerometer-Measured Sedentary Behavior and Risk of CVD A study of the association between accelerometer-measured sedentary behavior with risk of specific CV outcomes, including potential relations with moderate to vigorous physical activity
  Journal of the American College of Cardiology, March 20, 2025
• Nonpharmacologic Management of Patients With HF A review of the optimal lifestyle recommendations including dietary interventions, exercise, and management of sleep-disordered breathing, mood disorders, and substance use.
  JACC: Heart Failure, March 20, 2025
• Valve Choice for TAVR: Much Left to re-SOLVE Elderly patients may fare similarly with either an SEV or a BEV, but for lifetime management in younger and/or lower-surgical-risk patients, relevant differences exist between the 2 platforms.
  Journal of the American College of Cardiology, December 04, 2024
• Responder Analyses Can Be Misleading The authors propose that anchor based analyses of continuous variable endpoints should be used to evaluate the clinical meaningfulness of observed treatment effects in clinical trials.
  Journal of the American College of Cardiology, November 27, 2024
• Revisiting ICDs for Primary Prevention in HFrEF A review of the data underpinning guideline recommendations for implantable cardioverter-defibrillators (ICDs) to reduce the risk of SCD in patients with HFrEF and pragmatic guidance for clinicians.
  JACC: Heart Failure, February 28, 2025
• Oxidized Phospholipids and Calcific Aortic Valvular Disease A study looking at the association of oxidized phospholipids carried by apolipoprotein B-100–containing lipoproteins, including Lp (a), and calcific aortic valve disease.
  Journal of the American College of Cardiology, February 21, 2025
• Antiplatelets in Cardiac Patients Requiring Noncardiac Surgery An editorial on how to manage antiplatelet therapy in patients with coronary stents who require noncardiac surgery in light of the ASSURE DES study.
  Journal of the American College of Cardiology, February 14, 2025
• MRAs in HF: Established and Emerging Roles A comprehensive review of the current data on MRAs for HF and the future direction of nonsteroidal MRA research, that also explores the causes of MRA underutilization.
  JACC: Heart Failure, February 07, 2025
• Consequences of Discontinuing Long-Term Drugs in HFrEF Currently patients with HF are prescribed many drugs for their lifetime. This paper reviews strategies to assess whether efficacy persists and the potential consequences of discontinuation.
  Journal of the American College of Cardiology, January 03, 2025
• Cardiac Myosin Inhibitors: Is the Emperor Wearing Any Clothes? A commentary on the need for better trials and long-term data for the myosin inhibitors aficamten and mavacamten in obstructive hypertrophic cardiomyopathy.
  Journal of the American College of Cardiology, December 27, 2024
• Heart Failure Drug Development Over the Eras A summary of current efforts of the Heart Failure Collaboratory that highlights important concepts in the contemporary landscape of HF drug development.
  JACC: Heart Failure, December 20, 2024
• Takeaways From Six Substudies of the Semaglutide Trials A summary of findings from the 6 Substudies of the SELECT, STEP-HFpEF, and FLOW Trials
  Journal of the American College of Cardiology, December 06, 2024
• HF Risk Assessment Using Biomarkers in Patients With AF An analysis from COMBINE-Af on the incremental prognostic performance of NT-proBNP, hs-cTnT, and GDF-15 for HF risk stratification in patients with AF.
  Journal of the American College of Cardiology, December 13, 2024
• Distinct Comorbidity Clusters in Patients With Acute HF Five distinct multimorbidity groups were identified from the RELAX-AHF-2 trial population, showing variations in clinical outcomes.
  JACC: Heart Failure, November 22, 2024
• Triglycerides and Cardiovascular Risk Are triglycerides a true risk factor for ASCVD, or is it the lipoproteins that carry them that are the pathogenetic culprit?
  Journal of the American College of Cardiology, August 07, 2024
• Temporal Trends in Takotsubo Syndrome An analysis of nearly 4,000 cases of Takotsubo syndrome from the InterTAK registry.
  Journal of the American College of Cardiology, July 31, 2024
• Obesity and Weight Loss Strategies in Heart Failure A review of published data on the epidemiology of obesity and HF, the rationale and caveats regarding intentional weight loss for patients with HF across lifestyle, surgical, and medication domains.
  JACC: Heart Failure, November 01, 2024
• Patch Wearable Defibrillator Works, If Patients Stick With It The Jewel IDE trial supports the use of a water-resistant wearable cardioverter-defibrillator patch in adults at risk for sudden cardiac arrest; however 38% of patients exited the study early..
  Journal of the American College of Cardiology, October 25, 2024
• Stable Angina: A Patient-Centered Approach A review of the complementary role of coronary revascularization, optimal medical therapy, and lifestyle interventions in the management of stable angina, and the importance of an approach that targets the pathobiology.
  Journal of the American College of Cardiology, October 18, 2024